NeOnc Technologies Holdings, Inc Common Stock

NeOnc Technologies Holdings, Inc Common Stock

Yahoo Finance • 23 days ago

NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy

With a stock price of $4.64, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) is among the 8 Best Up and Coming Penny Stocks to Buy Now. On May 19, Alliance Global initiated coverage of NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) with... Full story

Yahoo Finance • 25 days ago

The Next Great AI Revolution May Be Drug Delivery

DENVER, May 29, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – When most investors think about artificial intelligence, they picture chatbots, automation platforms, semiconductors, or cloud infrastructure. Yet some of the most import... Full story

Yahoo Finance • 27 days ago

Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine

DENVER, May 27, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – Biotechnology investors are entering one of the most catalyst-heavy clinical cycles in years as a wave of Phase 2 and Phase 3 programs begins reshaping expectations acros... Full story

Yahoo Finance • last month

NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones

DENVER, May 19, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – NeOnc Technologies (NASDAQ:NTHI), a clinical-stage biotechnology company focused on treatments for central nervous system (CNS) cancers, has recently attracted growing at... Full story

Yahoo Finance • 2 months ago

Where Executives Are Doubling Down on Their Companies’ Fortunes

DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- 24/7 Market News and NeOnc Technology -- As market participants are sifting through data, one signal often cuts through the noise: insiders putting real money to work. Executives and strategic sta... Full story

Yahoo Finance • 7 months ago

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

CALABASAS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous system (CNS) cancers, today ann... Full story

Yahoo Finance • 7 months ago

NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update

CALABASAS, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) canc... Full story

Yahoo Finance • 7 months ago

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- NeOncTechnologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing novel brain-penetrant therapeutics for patients with malignant... Full story

Yahoo Finance • 8 months ago

NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors

CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 09, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies f... Full story

Yahoo Finance • 9 months ago

NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board

NeOnc Technologies Holdings, Inc.image1.jpeg CALABASAS, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering the... Full story

Yahoo Finance • 9 months ago

NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board

CALABASAS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) can... Full story

Yahoo Finance • 9 months ago

Blue Gold Appoints Quazar’s Sameer Salgar to Advisory Board to Establish UAE Ties and Guide Digital Gold Strategy

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Blue Gold Limited (Nasdaq: BGL) ("Blue Gold" or the “Company”), a next-generation gold development and technology company, today announced the appointment of Sameer Salgar, Founding Partner an... Full story

Yahoo Finance • 9 months ago

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

CALABASAS, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (... Full story

Yahoo Finance • 10 months ago

NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board

CALABASAS, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the... Full story

Yahoo Finance • 10 months ago

NeOnc Technologies Holdings GAAP EPS of $0.30

* NeOnc Technologies Holdings press release [https://seekingalpha.com/pr/20205072-neonc-technologies-holdings-reports-second-quarter-2025-results-and-provides-operational] (NASDAQ:NTHI [https://seekingalpha.com/symbol/NTHI]): Q2 GAAP EPS... Full story

Yahoo Finance • 10 months ago

NeOnc Technologies to restate first quarter 2025 financials due to RSU expense error

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a small-cap biotech company with a market capitalization of $97.42 million, announced Monday that its unaudited consolidated financial statements for the quarter ended March 31, 2025, should... Full story

Yahoo Finance • 10 months ago

NeOnc secures $50 million investment following UAE subsidiary formation

ABU DHABI - NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), currently valued at $91.14 million, announced Monday that its subsidiary NuroMENA Holdings Ltd. has been officially incorporated by the Abu Dhabi Global Market (ADGM), fulfilling... Full story

Yahoo Finance • 11 months ago

NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia

CALABASAS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi–Phase 2 clinical-stage biotechnology company focused on breakthrough therapies for central nervous system (CNS) malignancies,... Full story

Yahoo Finance • 11 months ago

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform

CALABASAS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, today announc... Full story

Yahoo Finance • last year

NeOnc Technologies files to sell 10.02M shares of common stock by selling shareholders

* NeOnc Technologies (NASDAQ:NTHI [https://seekingalpha.com/symbol/NTHI]) filed a prospectus to resale 10.02M shares of common stock. * The company will not receive any proceeds from the sale of ordinary shares by the selling sharehold... Full story